The Effect of Bleomycin Embolization on Symptomatic Improvement and Hemangioma Size among Patients with Giant Liver Hemangiomas

Journals Menu

Follow SCIRP

ISSN Print: 2163-9450
ISSN Online: 2163-9469
www.scirp.org/journal/ojgas/
E-mail: ojgas@scirp.org

Citations

"The Effect of Bleomycin Embolization on Symptomatic Improvement and Hemangioma Size among Patients with Giant Liver Hemangiomas"
written by Mahir Kirnap, Fatih Boyvat, Sedat Boyacioglu, Fatih Hilmioglu, Gokhan Moray, Mehmet Haberal,
published by Open Journal of Gastroenterology, Vol.8 No.4, 2018

has been cited by the following article(s):

[1]	Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response
	CardioVascular and …, 2024

[2]	Karaciğer dev hemanjiyomlarinin tedavisinde bleomisin ve lipiodol karışımı ile kemoembolizasyonun güvenilirliği ve etkinliği
	Cukurova Medical Journal, 2022

[3]	Safety and efficacy of chemoembolization with mixture of bleomycin and lipiodol in the treatment of giant liver hemangiomas
	Cukurova Medical Journal, 2022

[4]	Percutaneous sclerotherapy with bleomycin and ethiodized oil: a promising treatment in symptomatic giant liver hemangioma
	2021

[5]	Effectiveness of transarterial embolization in treatment of symptomatic hepatic hemangiomas: systematic review and meta-analysis
	2020

[6]	Transarterial (Chemo-) Embolization and Lipiodolization for Hepatic Haemangioma
	2019

[7]	Hemangioma Laringoesofágico en adulto. Reporte de caso clínico.
	2019

Follow SCIRP